Global Personalized Cancer Vaccines Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Lung Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Colorectal Cancer
  • 1.3.5 Leukemia
  • 1.3.6 Prostate Cancer
  • 1.3.7 Cervical Cancer
  • 1.3.8 Glioblastoma
  • 1.3.9 Others
• 1.4 Market by Application
  • 1.4.1 Global Personalized Cancer Vaccines Market Share by Application: 2020 VS 2026
  • 1.4.2 Hospitals
  • 1.4.3 Homecare
  • 1.4.4 Specialty Clinics
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Personalized Cancer Vaccines Market Perspective (2015-2026)
• 2.2 Personalized Cancer Vaccines Growth Trends by Regions
  • 2.2.1 Personalized Cancer Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Personalized Cancer Vaccines Historic Market Share by Regions (2015-2020)
  • 2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Regions (2021-2026)
• 2.3 Personalized Cancer Vaccines Industry Dynamic
  • 2.3.1 Personalized Cancer Vaccines Market Trends
  • 2.3.2 Personalized Cancer Vaccines Market Drivers
  • 2.3.3 Personalized Cancer Vaccines Market Challenges
  • 2.3.4 Personalized Cancer Vaccines Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Personalized Cancer Vaccines Players by Market Size
  • 3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2015-2020)
  • 3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2015-2020)
• 3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Personalized Cancer Vaccines Revenue
• 3.4 Global Personalized Cancer Vaccines Market Concentration Ratio
  • 3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2019
• 3.5 Key Players Personalized Cancer Vaccines Area Served
• 3.6 Key Players Personalized Cancer Vaccines Product Solution and Service
• 3.7 Date of Enter into Personalized Cancer Vaccines Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cancer Vaccines Breakdown Data by Type

• 4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2015-2020)
• 4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2021-2026)

5 Personalized Cancer Vaccines Breakdown Data by Application

• 5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2015-2020)
• 5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Personalized Cancer Vaccines Market Size (2015-2026)
• 6.2 North America Personalized Cancer Vaccines Market Size by Type (2015-2020)
• 6.3 North America Personalized Cancer Vaccines Market Size by Application (2015-2020)
• 6.4 North America Personalized Cancer Vaccines Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Personalized Cancer Vaccines Market Size (2015-2026)
• 7.2 Europe Personalized Cancer Vaccines Market Size by Type (2015-2020)
• 7.3 Europe Personalized Cancer Vaccines Market Size by Application (2015-2020)
• 7.4 Europe Personalized Cancer Vaccines Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2015-2026)
• 8.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Personalized Cancer Vaccines Market Size (2015-2026)
• 9.2 Latin America Personalized Cancer Vaccines Market Size by Type (2015-2020)
• 9.3 Latin America Personalized Cancer Vaccines Market Size by Application (2015-2020)
• 9.4 Latin America Personalized Cancer Vaccines Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2015-2026)
• 10.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Advaxis Inc
  • 11.1.1 Advaxis Inc Company Details
  • 11.1.2 Advaxis Inc Business Overview
  • 11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction
  • 11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2015-2020))
  • 11.1.5 Advaxis Inc Recent Development
• 11.2 Personalis
  • 11.2.1 Personalis Company Details
  • 11.2.2 Personalis Business Overview
  • 11.2.3 Personalis Personalized Cancer Vaccines Introduction
  • 11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 11.2.5 Personalis Recent Development
• 11.3 Hoffmann-La Roche Ltd
  • 11.3.1 Hoffmann-La Roche Ltd Company Details
  • 11.3.2 Hoffmann-La Roche Ltd Business Overview
  • 11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction
  • 11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 11.3.5 Hoffmann-La Roche Ltd Recent Development
• 11.4 BioNtech
  • 11.4.1 BioNtech Company Details
  • 11.4.2 BioNtech Business Overview
  • 11.4.3 BioNtech Personalized Cancer Vaccines Introduction
  • 11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 11.4.5 BioNtech Recent Development
• 11.5 Celldex
  • 11.5.1 Celldex Company Details
  • 11.5.2 Celldex Business Overview
  • 11.5.3 Celldex Personalized Cancer Vaccines Introduction
  • 11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 11.5.5 Celldex Recent Development
• 11.6 CureVac AG
  • 11.6.1 CureVac AG Company Details
  • 11.6.2 CureVac AG Business Overview
  • 11.6.3 CureVac AG Personalized Cancer Vaccines Introduction
  • 11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 11.6.5 CureVac AG Recent Development
• 11.7 Genetech
  • 11.7.1 Genetech Company Details
  • 11.7.2 Genetech Business Overview
  • 11.7.3 Genetech Personalized Cancer Vaccines Introduction
  • 11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 11.7.5 Genetech Recent Development
• 11.8 Genocea
  • 11.8.1 Genocea Company Details
  • 11.8.2 Genocea Business Overview
  • 11.8.3 Genocea Personalized Cancer Vaccines Introduction
  • 11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 11.8.5 Genocea Recent Development
• 11.9 Gritstone Oncology
  • 11.9.1 Gritstone Oncology Company Details
  • 11.9.2 Gritstone Oncology Business Overview
  • 11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction
  • 11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 11.9.5 Gritstone Oncology Recent Development
• 11.10 ISA Pharmaceuticals
  • 11.10.1 ISA Pharmaceuticals Company Details
  • 11.10.2 ISA Pharmaceuticals Business Overview
  • 11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction
  • 11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 11.10.5 ISA Pharmaceuticals Recent Development
• 11.11 Merck
  • 10.11.1 Merck Company Details
  • 10.11.2 Merck Business Overview
  • 10.11.3 Merck Personalized Cancer Vaccines Introduction
  • 10.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 10.11.5 Merck Recent Development
• 11.12 Moderna Therapeutics
  • 10.12.1 Moderna Therapeutics Company Details
  • 10.12.2 Moderna Therapeutics Business Overview
  • 10.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction
  • 10.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2015-2020)
  • 10.12.5 Moderna Therapeutics Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer